Header Logo

Connection

MALCOLM BRENNER to Antigens

Back to Details
This is a "connection" page, showing publications MALCOLM BRENNER has written about Antigens.
MALCOLM BRENNER
Connection Strength
0.179
Antigens
  1. Design and development of therapies using chimeric antigen receptor-expressing T cells. Immunol Rev. 2014 Jan; 257(1):107-26.
    View in: PubMed
    Score: 0.106
  2. The immunogenicity of virus-derived 2A sequences in immunocompetent individuals. Gene Ther. 2013 Sep; 20(9):958-62.
    View in: PubMed
    Score: 0.025
  3. Immunotherapy of human cancers using gene modified T lymphocytes. Curr Gene Ther. 2009 Oct; 9(5):396-408.
    View in: PubMed
    Score: 0.020
  4. Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. Blood. 2005 Jun 15; 105(12):4677-84.
    View in: PubMed
    Score: 0.014
  5. Options for T-cell based therapies. Vox Sang. 2004 Jul; 87 Suppl 2:230-4.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.